CORTISONE ACETATE (cortisone acetate) by Molecular Devices is clinical pharmacology: naturally occurring glucocorticoids (hydrocortisone and cortisone), which also have salt-retaining properties, are used as replacement therapy in adrenocortical deficiency states. Approved for prostate cancer, atopic dermatitis, chronic kidney disease and 1 more indications. First approved in 1952.
Drug data last refreshed 19h ago · AI intelligence enriched 1w ago
Cortisone Acetate is a naturally occurring glucocorticoid available as an oral tablet that functions as both a replacement therapy for adrenocortical deficiency and a potent anti-inflammatory agent. It modifies immune responses and causes significant metabolic effects, making it useful across multiple organ system disorders. The drug has been in clinical use since 1952 and remains a foundational corticosteroid in the pharmacopeia.
As an aging molecule approaching loss of exclusivity with minimal current pipeline activity, career opportunities are limited to maintenance and generic transition roles rather than growth-oriented positions.
CLINICAL PHARMACOLOGY: Naturally occurring glucocorticoids (hydrocortisone and cortisone), which also have salt-retaining properties, are used as replacement therapy in adrenocortical deficiency states. They are also used for their potent anti-inflammatory effects in disorders of many organ…
Worked on CORTISONE ACETATE at Molecular Devices? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Pharmacokinetics and Bioavailability of Hydrocortisone Acetate Suppositories
Upgrade to Pro to access CMS Part B ASP pricing data and other premium pharma intelligence.
Upgrade to Pro — $25/moWorking on Cortisone Acetate offers limited career advancement opportunities due to its mature lifecycle and approaching loss of exclusivity; roles are primarily defensive and focused on compliance, safety monitoring, and generic transition management. This is not a growth platform for ambitious pharma professionals seeking dynamic commercial or innovative clinical roles.